← 返回首页
美国 · 平台与数据 · MarketBeat

Vertex Pharmaceuticals Prepares for Key Kidney Drug Decision as Pipeline Readouts Loom

来源:MarketBeat · 美国 21 分钟前
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

详细摘要

Vertex Pharmaceuticals (NASDAQ:VRTX) is preparing for a Nov. 30 U.S. regulatory decision on its kidney disease treatment povetacicept, while awaiting clinical results across kidney disease, chronic pain and other conditions, company executives said at a UBS investor event. Susie Lisa, Vertex’s seni

在 MarketBeat 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketbeat.com)

推荐阅读